This study seeks to enhance our understanding of the growth dynamics of VHL-related hemangioblastomas, with a particular focus on determining the effect of dual HIF-α isoform inhibition on tumor progression, which could potentially contribute to the development of novel pharmacological strategies. The gene discussed is VHL; the disease is neoplasm.